BioSpace News Archive

Fact.MR, a global research & consulting firm, in their recent edition of the report, indicated that the bone marrow processing systems market is slated to record a robust CAGR in 2021 and beyond.

Fact.MR, a global research & consulting firm, in their latest edition of the report, projected that the thermasonic ultrasound gel warmers market will grow at a rapid CAGR Over the forecast period.

The albumin & creatinine tests market is prognosticated to witness promising growth across the assessment period of 2020-2030.

The critical care therapeutics market is predicted to rise at a stellar growth rate over the forecast period from 2020 to 2030.

BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving medicines, today announced that the company will participate virtually in the following scientific and investor events:

According to the American Cancer Society, as many as 10% of pancreatic cancers are caused by familial and hereditary risk factors. PanFAM-1 is the largest prospective study to date, focusing on early diagnosis in high-risk individuals with Familial/Hereditary Pancreatic Cancer (FPC).

Nordic Nanovector ASA (OSE: NANOV) announces that it will report its results for the fourth quarter and full year 2020 on Thursday, 18 February 2021 .

ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter 2020 financial results on Thursday, February 18, 2021, before the U.S. financial markets open. Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will host a conference call to discuss the results as follows: Time 8:30 A.M EST Tol

Key new findings by the Institut Pasteur concerning the gene target GJB2, enables Sensorion to potentially address important hearing loss segments in adults and children

ReSuture has recently announced that they have been selected for the National Science Foundation’s Small Business Innovation Research (SBIR) award. ReSuture will receive $256,000 of non-dilutive funding for research and development related to their proposal Open Vascular Training System for Surgical Skill Acquisition and Evaluation.